Latest News and Press Releases
Want to stay updated on the latest news?
-
DANVERS, Mass., July 31, 2014 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2015 revenue of $48.8...
-
DANVERS, Mass., July 16, 2014 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD) announced today that on Thursday, July 31, 2014, the Company will release financial results for the first quarter of...
-
DANVERS, Mass., July 1, 2014 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, announced today that it has acquired ECP...
-
DANVERS, Mass., June 4, 2014 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman,...
-
DANVERS, Mass., June 4, 2014 (GLOBE NEWSWIRE) -- The MedTech and BioTech Veterans Program (MVP) announced today it will host the Boston area's first-ever Student Veteran Re-careering Seminar for...
-
DANVERS, Mass., June 3, 2014 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported that physicians have implanted more than...
-
DANVERS, Mass., May 27, 2014 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman,...
-
DANVERS, Mass., May 21, 2014 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced it has received approval for implementation...
-
DANVERS, Mass., May 19, 2014 (GLOBE NEWSWIRE) -- Abiomed Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, notes that there will be approximately eight potential...
-
Record Patient Utilization and 200% Growth in Impella CP Patients Abiomed Completes Impella 2.5 Submission for Pre-Market Approval (PMA) DANVERS, Mass., May 1, 2014 (GLOBE NEWSWIRE) --...